Patient-Reported Outcomes of participants in the phase II/III QUILT 3.032 study of N-803 plus BCG in BCG-unresponsive non-muscle invasive bladder cancer were published by the peer-reviewed journal Urology Practice.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe